Table I.
Mean age, years (range) | 27.2 (12–39) |
Surgical procedures, n (%) | |
Cystectomy | 1 (3.5) |
USO | 10 (34.5) |
USO, OMT | 3 (10.3) |
USO, OMT, LA | 15 (51.7) |
Tumor histology, n (%) | |
Mucinous | 16 (55.2) |
Serous | 5 (17.2) |
Endometrioid | 5 (17.2) |
Clear cell | 3 (10.4) |
Grade, an | |
G1 | 13 |
G2 | 10 |
G3 | 3 |
FIGO stage, n (%) | |
IA | 14 (48.3) |
G1 | 6 |
G2 | 5 |
G3 | 2 |
Clear cell | 1 |
IC1 | 6 (20.7) |
G1 | 3 |
G2 | 3 |
G3 | 0 |
Clear cell | 0 |
IC3 | 9 (31.0) |
G1 | 4 |
G2 | 2 |
G3 | 1 |
Clear cell | 2 |
Adjuvant chemotherapy, n (%) | |
Yes | 19 (65.5) |
No | 10 (34.5) |
Recurrence, n (%) | |
No | 24 (82.3) |
Yes | 5 (17.2) |
Clinical outcome, n (%) | |
NED | 26 (89.7) |
AWD | 1 (3.4) |
DOD | 2 (6.9) |
Menstruation, n | |
Regular | 21 |
Irregular | 1 |
Amenorrhea | 2 |
Unknown | 5 |
Reproductive outcome, bn | |
Parity | 7 |
Primary symptom, cn (%) | |
Birth | 6 |
Abdominal symptom | 24 (82.8) |
Atypical genital bleeding | 3 (10.3) |
Medical examination | 2 (6.9) |
Unknown | 1 (3.4) |
Clear cell is not graded.
Pregnancy in 5 patients, Birth in 4 patients.
One patient exhibited two symptoms. USO, unilateral salpingo-oophrectomy; OMT, omentectomy; LA, lymphadenectomy; NED, no evidence of disease; AWD, alive with disease; DOD, dead of disease.